In addition, the company will host several sponsored education events at the Optometry’s Meeting in Washington, D.C. from June 21-24, 2023. The poster presentations will include data from the two ...
A Total of 11 Poster Presentations Will Be Presented, Including Data from Two Pivotal Phase 3 Trials and 12-Month Safety Extension Trial of MIEBO™ (Perfluorohexyloctane Ophthalmic Solution) VAUGHAN, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback